Circulating endothelial cells: Markers and mediators of vascular damage

Current Stem Cell Research and Therapy

Volumn 5, Issue 4, 2010, Pages 294-302

  Erdbruegger, Uta ^a   Dhaygude, Ajay ^b   Haubitz, Marion ^c   Woywodt, Alexander ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Blood markers; Circulating endothelial cells; Vascular damage

Indexed keywords

ANTIGEN; CD141 ANTIGEN; CD146 ANTIGEN; CD31 ANTIGEN; CD62E ANTIGEN; ENDOGLIN; INTERCELLULAR ADHESION MOLECULE 1; THROMBOPLASTIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ANCA ASSOCIATED VASCULITIS; ANGIOPLASTY; AORTITIS; APOPTOSIS; BEHCET DISEASE; BLOOD VESSEL INJURY; BONE MARROW TRANSPLANTATION; BREAST CANCER; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL INTERACTION; CHRONIC VEIN INSUFFICIENCY; CIRCULATING ENDOTHELIAL CELL; CONGESTIVE HEART FAILURE; CYTOMEGALOVIRUS INFECTION; DISEASE MARKER; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HUMAN; IMMUNOMAGNETIC SEPARATION; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; LUPUS VULGARIS; LYMPHOMA; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PHENOTYPE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RICKETTSIOSIS; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SICKLE CELL ANEMIA; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THALASSEMIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSITIONAL BLINDNESS; VASCULAR ENDOTHELIUM; VASCULITIS;

ANIMALS; ANTIGENS, CD146; BIOLOGICAL MARKERS; BLOOD CIRCULATION; CELL ADHESION; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; VASCULAR DISEASES;

EID: 78649883698     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488810793351721     Document Type: Review

References (120)

1. Bouvier CA, Gaynor E, Cintron JR, Bernhardt B, Spaet T. Circulating endothelium as an indication of vascular injury. Thromb Diath Haemorrh 1970; 40: 163.
2. Hladovec J, Prerovsky I, Stanek V, Fabian J. Circulating endothelial cells in acute myocardial infarction and angina pectoris. Klin Wochenschr 1978; 56: 1033-6.
3. Wright HP, Giacometti NJ. Circulating endothelial cells and arterial endothelial mitosis in anaphylactic shock. Br J Exp Pathol 1972; 53: 1-4.
4. Gaynor E, Bouvier CA, Cintron JR. A technique for locating rare cells in the circulation for ultramicroscopy. Proc Soc Exp Biol Med 1970; 133: 520-3.
5. Jaffe EA. Cell biology of endothelial cells. Hum Pathol 1987; 18: 234-9.
6. Percivalle E, Revello MG, Vago L, Morini F, Gerna G. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest 1993; 92: 663-70.
7. Sbarbati R, de Boer M, Marzilli M, Scarlattini M, Rossi G, van Mourik JA. Immunologic detection of endothelial cells in human whole blood. Blood 1991; 77: 764-9.
8. George F, Brisson C, Poncelet P, et al. Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb Haemost 1992; 67: 147-53.
9. Blann AD, Woywodt A, Bertolini F, et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005; 93: 228-35.
10. Woywodt A, Blann AD, Kirsch T, et al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J Thromb Haemost 2006; 4: 671-7.
11. Woywodt A, Goldberg C, Scheer J, Regelsberger H, Haller H, Haubitz M. An improved assay for enumeration of circulating endothelial cells. Ann Hematol 2004; 83: 491-4.
12. CD146. Protein reviews on the web, 2003., at http://mpr.nci.nih.-gov/prow/). [Accessed January 24, 2010].
13. Woywodt A, Blann A, Kirsch T, Erdbruegger U, Haubitz M, Dignat-George F. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J Thromb Haemost 2006; 4: 671-7.
14. Hamid SA, Daly C, Campbell S. Visualization of live endothelial cells ex vivo and in vitro. Microvasc Res 2003; 66: 159-63.
15. Stephenson TJ, Griffiths DW, Mills PM. Comparison of Ulex europaeus I lectin binding and factor VIII-related antigen as markers of vascular endothelium in follicular carcinoma of the thyroid. Histopathology 1986; 10: 251-60.
16. Rowand JL, Martin G, Doyle GV, et al. Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A 2007; 71: 105-13.
17. Holmen C, Elsheikh E, Stenvinkel P, et al. Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. J Am Soc Nephrol 2005; 16: 3110-20.
18. Moroni G, Del Papa N, Moronetti LM, et al. Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease. Kidney Int 2005; 68: 562-8.
19. Del Papa N, Colombo G, Fracchiolla N, et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum 2004; 50: 1296-304.
20. Mancuso P, Rabascio C, Bertolini F. Strategies to investigate circulating endothelial cells in cancer. Pathophysiol Haemost Thromb 2003; 33: 503-6.
21. Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001; 97: 3658-61.
22. Khan SS, Solomon MA, McCoy JP, Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005; 64: 1-8.
23. Goon PK, Boos CJ, Stonelake PS, Blann AD, Lip GY. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison. Thromb Haemost 2006; 96: 45-52.
24. Mancuso P, Antoniotti P, Quarna J, et al. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res 2009; 15: 267-73.
25. Duda DG, Cohen KS, Scadden DT, Jain RK. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007; 2: 805-10.
26. Strijbos MH, Gratama JW, Kraan J, Lamers C, Bakker Md, Sleijfer S. Circulating endothelial cells in oncology: pitfalls and promises. Br J Cancer 2008; 98: 1731-5.
27. Mancuso P, Calleri A, Cassi C, et al. Circulating endothelial cells as a novel marker of angiogenesis. Adv Exp Med Biol 2003; 522: 83-97.
28. Jacques N, Vimond N, Conforti R, et al. Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay. J Immunol Methods 2008; 337: 132-43.
29. Clarke LA, Shah V, Arrigoni F, et al. Quantitative detection of circulating endothelial cells in vasculitis: comparison of flow cytometry and immunomagnetic bead extraction. J Thromb Haemost 2008; 6: 1025-32.
30. Widemann A, Sabatier F, Arnaud L, et al. CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells. J Thromb Haemost 2008; 6: 869-76.
31. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCAassociated small-vessel vasculitis. Lancet 2003; 361: 206-10.
32. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999; 93: 2951-8.
33. Vargova K, Toth-Zsamboki E, Beres BJ, et al. Circulating endothelial cell count, plasma vWF and soluble ICAM-1 levels following primary or elective percutaneous coronary intervention. Atherosclerosis 2008; 198: 366-72.
34. Lee KW, Lip GY, Tayebjee M, Foster W, Blann AD. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005; 105: 526-32.
35. Quilici J, Banzet N, Paule P, et al. Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes. Circulation 2004; 110: 1586-91.
36. Wang C, Li H, Fu P, Zhang S, Xiu R. Serum C-reactive protein and circulating endothelial cells in patients with acute myocardial infarction. Clin Hemorheol Microcirc 2005; 32: 287-96.
37. Freestone B, Lip GY, Chong AY, Nadar S, Lee KW, Blann AD. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease. Thromb Haemost 2005; 94: 702-6.
38. Nadar SK, Lip GY, Lee KW, Blann AD. Circulating endothelial cells in acute ischaemic stroke. Thromb Haemost 2005; 94: 707-12.
39. Gao Y, Liu C, Zhang X, Gao J, Yang C. Circulating endothelial cells as potential markers of atherosclerosis. Can J Neurol Sci 2008; 35: 638-42.
40. Boos CJ, Lane DA, Karpha M, Beevers DG, Haynes R, Lip GY. Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. Chest 2007; 132: 1540-7.
41. Woywodt A, Goldberg C, Kirsch T, et al. Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis. Ann Rheum Dis 2006; 65: 164-8.
42. Haubitz M, Woywodt A. Circulating endothelial cells and vasculitis. Intern Med 2004; 43: 660-7.
43. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Tokutomi T, Sekine I. Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol 2003; 131: 536-40.
44. Yu X, Hirono KI, Ichida F, et al. Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease. Pediatr Res 2004; 55: 688-94.
45. Kluz J, Kopec W, Jakobsche-Policht U, Adamiec R. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis. Int Angiol 2009; 28: 192-201.
46. Clancy RM. Circulating endothelial cells and vascular injury in systemic lupus erythematosus. Curr Rheumatol Rep 2000; 2: 39-43.
47. Cugno M, Borghi MO, Lonati LM, et al. Patients with antiphospholipid syndrome display endothelial perturbation. J Autoimmun 2010; 34: 105-10.
48. George F, Brouqui P, Boffa MC, et al. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 1993; 82: 2109-16.
49. Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001; 163: 195-200.
50. Kas-Deelen AM, de Maar EF, Harmsen MC, Driessen C, van Son WJ, The TH. Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: effect of acute rejection. J Infect Dis 2000; 181: 721-4.
51. Drancourt M, George F, Brouqui P, Sampol J, Raoult D. Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads. J Infect Dis 1992; 166: 660-3.
52. Woywodt A, Schröder M, Gwinner W, et al. Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation 2003; 76: 1-4.
53. Woywodt A, Schroeder M, Mengel M, et al. Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension 2003; 41: 720-3.
54. Sudhir K, MacGregor JS, DeMarco T, et al. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries. Circulation 1994; 90: 3018-23.
55. Popa ER, Kas-Deelen AM, Hepkema BG, Van Son WJ, The TH, Harmsen MC. Donor-derived circulating endothelial cells after kidney transplantation. Transplantation 2002; 74: 1320-7.
56. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001; 357: 33-7.
57. Woywodt A, Scheer J, Hambach L, et al. Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation. Blood 2004; 103: 3603-5.
58. Woywodt A, Haubitz M, Buchholz S, Hertenstein B. Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 34: 1015-23.
59. Lefevre P, George F, Durand JM, Sampol J. Detection of circulating endothelial cells in thrombotic thrombocytopenic purpura. Thromb Haemost 1993; 69: 522.
60. Erdbruegger U, Woywodt A, Kirsch T, Haller H, Haubitz M. Circulating endothelial cells as a prognostic marker in patients with thrombotic microangiopathy. Am J Kidney Dis 2006; 48: 564-70.
61. Canbakan B, Keven K, Tutkak H, Danisman N, Ergun I, Nergizoglu G. Circulating endothelial cells in preeclampsia. J Hum Hypertens 2007; 21: 558-63.
62. Grundmann M, Woywodt A, Kirsch T, et al. Circulating endothelial cells: a marker of vascular damage in patients with preeclampsia. Am J Obstet Gynecol 2008; 198: 317 e1-5.
63. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997; 337: 1584-90.
64. Strijbos MH, Landburg PP, Nur E, et al. Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia? Blood Cells Mol Dis 2009; 43: 63-7.
65. Go RS, Jobe DA, Asp KE, et al. Circulating endothelial cells in patients with chronic lymphocytic leukemia. Ann Hematol 2008; 87: 369-73.
66. Gora-Tybor J, Jamroziak K, Szmigielska-Kaplon A, et al. Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia. Leuk Lymphoma 2009; 50: 62-7.
67. Alonci A, Allegra A, Bellomo G, et al. Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases. Hematol Oncol 2008; 26: 235-9.
68. Beerepoot LV, Mehra N, Vermaat JS, Zonnenberg BA, Gebbink MF, Voest EE. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004; 15: 139-45.
69. Goodale D, Phay C, Brown W, et al. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer. Cytometry B Clin Cytom 2009; 76: 107-17.
70. Calleri A, Bono A, Bagnardi V, et al. Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab. Clin Cancer Res 2009; 15: 7652-7.
71. Zurita AJ, Jonasch E, Wu HK, Tran HT, Heymach JV. Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma. Cancer 2009; 115: 2346-54.
72. Georgiou HD, Namdarian B, Corcoran NM, Costello AJ, Hovens CM. Circulating endothelial cells as biomarkers of prostate cancer. Nat Clin Pract Urol 2008; 5: 445-54.
73. Li H, Raia V, Bertolini F, Price DK, Figg WD. Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer model. BJU Int 2008; 101: 884-8.
74. Duda DG, Cohen KS, di Tomaso E, et al. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. J Clin Oncol 2006; 24: 1449-53.
75. Kawaishi M, Fujiwara Y, Fukui T, et al. Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel. J Thorac Oncol 2009; 4: 208-13.
76. Wang J, Huang C, Wei XY, et al. Changes of activated circulating endothelial cells and survivin in patients with non-small cell lung cancer after antiangiogenesis therapy. Chin Med J (Engl) 2008; 121: 2234-40.
77. Twardowski PW, Smith-Powell L, Carroll M, et al. Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib. Cancer Invest 2008; 26: 53-9.
78. Goon PK, Lip GY, Boos CJ, Stonelake PS, Blann AD. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 2006; 8: 79-88.
79. Woywodt A, Bahlmann FH, de Groot K, Haller H, Haubitz M. Circulating endothelial cells: Life, death and detachment of the endothelial cell layer. Nephrol Dial Transplant 2002; 17: 1728-30.
80. Dignat-George F, Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 2000; 65: 215-20.
81. Bull TM, Golpon H, Hebbel RP, et al. Circulating endothelial cells in pulmonary hypertension. Thromb Haemost 2003; 90: 698-703.
82. Swerlick RA, Lee KH, Wick TM, Lawley TJ. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 1992; 148: 78-83.
83. Butthep P, Rummavas S, Wisedpanichkij R, Jindadamrongwech S, Fucharoen S, Bunyaratvej A. Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. Am J Hematol 2002; 70: 100-6.
84. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-7.
85. Ingber D. Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J Cell Biochem 1991; 47: 236-41.
86. Oguey D, George PW, Ruegg C. Disruption of integrin-dependent adhesion and survival of endothelial cells by recombinant adenovirus expressing isolated beta integrin cytoplasmic domains. Gene Ther 2000; 7: 1292-303.
87. Visser MR, Jacob HS, Goodman JL, McCarthy JB, Furcht LT, Vercellotti GM. Granulocyte-mediated injury to herpes simplex virus-infected human endothelium. Lab Invest 1989; 60: 296-304.
88. Grosjean J, Kiriakidis S, Reilly K, Feldmann M, Paleolog E. Vascular endothelial growth factor signalling in endothelial cell survival: A role for NFkappaB. Biochem Biophys Res Commun 2006; 340: 984-94.
89. Ballieux BE, Hiemstra PS, Klar-Mohamad N, et al. Detachment and cytolysis of human endothelial cells by proteinase 3. Eur J Immunol 1994; 24: 3211-5.
90. Boehme MW, Galle P, Stremmel W. Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 2002; 107: 340-9.
91. Harlan JM, Killen PD, Harker LA, Striker GE, Wright DG. Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest 1981; 68: 1394-403.
92. Ruegg C, Dormond O, Foletti A. Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target? Endothelium 2002; 9: 151-60.
93. Li M, Carpio DF, Zheng Y, et al. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 2001; 166: 7128-35.
94. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-8.
95. Botto M, Dell'Agnola C, Bygrave AE, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19: 56-9.
96. Chen Q, Stone PR, McCowan LM, Chamley LW. Phagocytosis of necrotic but not apoptotic trophoblasts induces endothelial cell activation. Hypertension 2006; 47: 116-21.
97. Kirsch T, Woywodt A, Beese M, et al. Engulfment of apoptotic cells by microvascular endothelial cells induces proinflammatory responses. Blood 2007; 109: 2854-62.
98. Yang JJ, Preston GA, Alcorta DA, et al. Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA). Kidney Int 2002; 62: 1638-49.
99. Mayet W, Schwarting A, Barreiros AP, Schlaak J, Neurath M. Anti-PR-3 antibodies induce endothelial IL-8 release. Eur J Clin Invest 1999; 29: 973-9.
100. Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD. Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer 2009; 9: 182-94.
101. Bonnefoy A, Moura R, Hoylaerts MF. The evolving role of thrombospondin-1 in hemostasis and vascular biology. Cell Mol Life Sci 2008; 65: 713-27.
102. Kirsch T, Woywodt A, Klose J, et al. Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance. J Cell Mol Med 2010; 14(7): 1922-34.
103. Ziegler BL, Valtieri M, Porada GA, et al. KDR receptor: a key marker defining hematopoietic stem cells. Science 1999; 285: 1553-8.
104. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
105. Shmelkov SV, St Clair R, Lyden D, Rafii S. AC133/CD133/- Prominin-1. Int J Biochem Cell Biol 2005; 37: 715-9.
106. Murohara T, Ikeda H, Duan J, et al. Transplanted cord bloodderived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-36.
107. Delorme B, Basire A, Gentile C, et al. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost 2005; 94: 1270-9.
108. Erdbruegger U, Haubitz M, Woywodt A. Circulating endothelial cells: A novel marker of endothelial damage. Clin Chim Acta 2006; 373: 17-26.
109. Haubitz M, Dhaygude A, Woywodt A. Mechanisms and markers of vascular damage in ANCA-associated vasculitis. Autoimmunity 2009; 42: 605-14.
110. Woywodt A, Kirsch T, Haubitz M. Circulating endothelial cells in renal disease: markers and mediators of vascular damage. Nephrol Dial Transplant 2008; 23: 7-10.
111. Bonello L, Basire A, Sabatier F, Paganelli F, Dignat-George F. Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease. J Thromb Haemost 2006; 4: 979-81.
112. Makin AJ, Blann AD, Chung NA, Silverman SH, Lip GY. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. Eur Heart J 2004; 25: 371-6.
113. Chong AY, Lip GY, Freestone B, Blann AD. Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin. Eur J Heart Fail 2006; 8: 167-72.
114. Janssens D, Michiels C, Guillaume G, Cuisinier B, Louagie Y, Remacle J. Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: protective effect of Ginkor Fort in a randomized double-blind, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999; 33: 7-11.
115. Bardy M. Demonstration of pathological circulating endothelial cells in patients with amaurosis fugax. Trans Ophthalmol Soc U K 1980; 100: 385-7.
116. McClung JA, Naseer N, Saleem M, et al. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia 2005; 48: 345-50.
117. Camoin-Jau L, Kone-Paut I, Chabrol B, Sampol J, Dignat-George F. Circulating endothelial cells in Behcet's disease with cerebral thrombophlebitis. Thromb Haemost 2000; 83: 631-2.
118. Dang A, Wang B, Li W, et al. Plasma endothelin-1 levels and circulating endothelial cells in patients with aortoarteritis. Hypertens Res 2000; 23: 541-4.
119. Rajagopalan S, Somers EC, Brook RD, et al. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood 2004; 103: 3677-83.
120. Grefte A, van der Giessen M, van Son W, The TH. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis 1993; 167: 270-7.